NewGenIvf Group Limited
NewGenIvf Group Limited
Your view on NIVFW
Overview
What the company does, where it operates, and who runs it.
About NewGenIvf Group Limited
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Wing Fung Siu
- Headquarters
- PS Tower, Bangkok, BM, TH
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Wing Fung Siu
- Headquarters
- PS Tower, Bangkok, BM, TH
NewGenIvf Group Limited operates as an investment holding company specializing in providing assisted reproductive technologies (ART) for couples and individuals seeking fertility solutions. The company extends its operations across Thailand, Cambodia, Hong Kong, and Kyrgyzstan.
Its comprehensive suite of fertility treatments includes fundamental procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and embryo culture. NewGenIvf also offers crucial diagnostic and preparatory services like hormonal blood tests, screenings for infectious diseases, chromosome analysis, and hysteroscopy.
Additionally, the company provides specialized sperm services, encompassing analysis, sorting, washing, and cryopreservation, alongside oocyte (egg) freezing.
Beyond these core medical services, NewGenIvf facilitates surrogacy arrangements, offering essential ancillary care for surrogate mothers, including routine health check-ups, nutritional supplements, and prescribed medications.
To further enhance the patient journey, the company delivers a range of supplementary services such as dietary guidance, psychological counseling, acupuncture, and professional translation interpreters. These specialized medical and support services are delivered through the company's network of dedicated clinics.
Founded in 2010, NewGenIvf Group Limited is headquartered in Bangkok, Thailand.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for NewGenIvf Group Limited, and the rating behind it. NIVFW last traded at $0.01; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for NewGenIvf Group Limited. Starting points for NewGenIvf Group Limited: EPS -$491196.55, beta -0.04 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for NewGenIvf Group Limited. NewGenIvf Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for NewGenIvf Group Limited. Trailing twelve-month EPS for NewGenIvf Group Limited stands at -$491196.55. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for NewGenIvf Group Limited. NewGenIvf Group Limited has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
NewGenIvf Group Limited valued side by side against its closest peers. NewGenIvf Group Limited is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold NewGenIvf Group Limited, and how their positions are changing. At a $29,559 market value, institutional positions materially move NewGenIvf Group Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by NewGenIvf Group Limited executives and directors. Shares of NewGenIvf Group Limited have traded between $0.02 and $0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming NewGenIvf Group Limited. NewGenIvf Group Limited is a $29,559 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming NewGenIvf Group Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for NewGenIvf Group Limited. Coverage tracks NewGenIvf Group Limited within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.